Pillar Pacific Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Pillar Pacific Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1,999	Closed	-$219K	–	304
2017 Q1	$219K	Buy	+1,999	New	+$176K	0.03%	280
2016 Q3	–	Sell	-2,494	Closed	-$215K	–	305
2016 Q2	$215K	Sell	2,494 -306	-11%	-$26.4K	0.04%	273
2016 Q1	$223K	Sell	2,800 -155	-5%	-$14K	0.04%	268
2015 Q4	$372K	Buy	2,955 +40	+1%	+$4.83K	0.07%	184
2015 Q3	$304K	Sell	2,915 -75	-3%	-$9.64K	0.06%	198
2015 Q2	$369K	Buy	2,990 +380	+15%	+$47.9K	0.06%	181
2015 Q1	$308K	Sell	2,610 -75	-3%	-$8.99K	0.05%	207
2014 Q4	$319K	Buy	2,685 +30	+1%	+$3.38K	0.06%	204
2014 Q3	$298K	Buy	2,655 +165	+7%	+$15.7K	0.05%	206
2014 Q2	$236K	Buy	+2,490	New	+$175K	0.04%	264
2013 Q3	–	Sell	-3,000	Closed	-$240K	–	306
2013 Q2	$240K	Buy	+3,000	New	+$221K	0.06%	247

Other funds holding VRTX

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Pillar Pacific Capital Management's VRTX Position: Q2 2017 in Review

Pillar Pacific Capital Management sold out of Vertex Pharmaceuticals (VRTX) in Q2 2017, closing a stake of 1,999 shares — an estimated $219K sold.

Pillar Pacific Capital Management first reported a position in VRTX in Q2 2013 and held it in 11 quarters. The position peaked at $372K in Q4 2015. 582 funds tracked by Wall St. Rank hold VRTX as of Q2 2017.

Pillar Pacific Capital Management reported no remaining Vertex Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
Pillar Pacific Capital Management sold 1,999 Vertex Pharmaceuticals shares in Q2 2017, an estimated $219K.
Pillar Pacific Capital Management first reported a position in Vertex Pharmaceuticals in Q2 2013 and held it in 11 quarters.
Pillar Pacific Capital Management's Vertex Pharmaceuticals position peaked at $372K in Q4 2015.
582 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2017.

Based on Pillar Pacific Capital Management's 13F filing for Q2 2017, filed 27 Jul 2017.